Literature DB >> 24029729

Hyperthyroid monkeys: a nonhuman primate model of experimental Graves' disease.

Y Wang1, L P Wu, J Fu, H J Lv, X Y Guan, L Xu, P Chen, C Q Gao, P Hou, M J Ji, B Y Shi.   

Abstract

Graves' disease (GD) is a common organ-specific autoimmune disease with the prevalence between 0.5 and 2% in women. Several lines of evidence indicate that the shed A-subunit rather than the full-length thyrotropin receptor (TSHR) is the autoantigen that triggers autoimmunity and leads to hyperthyroidism. We have for the first time induced GD in female rhesus monkeys, which exhibit greater similarity to patients with GD than previous rodent models. After final immunization, the monkeys injected with adenovirus expressing the A-subunit of TSHR (A-sub-Ad) showed some characteristics of GD. When compared with controls, all the test monkeys had significantly higher TSHR antibody levels, half of them had increased total thyroxine (T₄) and free T₄, and 50% developed goiter. To better understand the underlying mechanisms, quantitative studies on subpopulations of CD4+T helper cells were carried out. The data indicated that this GD model involved a mixed Th1 and Th2 response. Declined Treg proportions and increased Th17:Treg ratio are also observed. Our rhesus monkey model successfully mimicked GD in humans in many aspects. It would be a useful tool for furthering our understanding of the pathogenesis of GD and would potentially shorten the distance toward the prevention and treatment of this disease in human.

Entities:  

Keywords:  Graves' disease; rhesus monkeys; thyrotropin receptor A-subunit

Mesh:

Substances:

Year:  2013        PMID: 24029729     DOI: 10.1530/JOE-13-0279

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

1.  A unique mouse strain that develops spontaneous, iodine-accelerated, pathogenic antibodies to the human thyrotrophin receptor.

Authors:  Basil Rapoport; Holly A Aliesky; Bianca Banuelos; Chun-Rong Chen; Sandra M McLachlan
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

2.  Evidence for the possible occurrence of Grave's disease in a blue-eyed black lemur (Eulemur flavifrons).

Authors:  Benoît Quintard; Marine Giorgiadis; Xavier Feirrera; Brice Lefaux; Christophe Schohn; Karin Lemberger
Journal:  Primates       Date:  2017-12-20       Impact factor: 2.163

Review 3.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

Review 4.  A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocrine       Date:  2019-09-27       Impact factor: 3.633

Review 5.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-01-22       Impact factor: 19.871

6.  Decreased Treg Cell and TCR Expansion Are Involved in Long-Lasting Graves' Disease.

Authors:  Ziyi Chen; Yufeng Liu; Shiqian Hu; Meng Zhang; Bingyin Shi; Yue Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

Review 7.  Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.

Authors:  Martin Ungerer; Julia Faßbender; Zhongmin Li; Götz Münch; Hans-Peter Holthoff
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.